1. Home
  2. IDYA vs MSGE Comparison

IDYA vs MSGE Comparison

Compare IDYA & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$35.87

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Madison Square Garden Entertainment Corp.

MSGE

Madison Square Garden Entertainment Corp.

N/A

Current Price

$73.52

Market Cap

3.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
MSGE
Founded
2015
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
IDYA
MSGE
Price
$35.87
$73.52
Analyst Decision
Strong Buy
Buy
Analyst Count
16
7
Target Price
$52.86
$61.00
AVG Volume (30 Days)
1.4M
532.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
N/A
EPS
N/A
1.59
Revenue
$218,710,000.00
$942,734,000.00
Revenue This Year
N/A
$10.53
Revenue Next Year
$201.05
$6.53
P/E Ratio
N/A
$46.33
Revenue Growth
3024.43
N/A
52 Week Low
$21.33
$35.31
52 Week High
$40.58
$82.79

Technical Indicators

Market Signals
Indicator
IDYA
MSGE
Relative Strength Index (RSI) 50.59 45.24
Support Level $32.85 $73.00
Resistance Level $38.17 $82.79
Average True Range (ATR) 1.46 2.34
MACD -0.47 -0.71
Stochastic Oscillator 5.75 6.69

Price Performance

Historical Comparison
IDYA
MSGE

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: